China’s Everest starts first phase operations to make mRNA vaccines
Everest Medicines, a Chinese biopharmaceutical company, announced the start of operations in the first phase at a global manufacturing site to make an.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Everest Medicines, a Chinese biopharmaceutical company, announced the start of operations in the first phase at a global manufacturing site to make an.
October 19, 2022: Researchers at Oregon State University have developed a proof of principle for a “universal” method of treating Covid-19. According to.
Moderna’s mRNA vaccine is being studied in combination with Merck’s Keytruda to treat patients with high-risk melanoma
COVID-19 vaccine maker BioNTech inks research deal with Australia